| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Physiology and 2 Endocrine Unit, A. Szent-Györgyi Medical University, 6720 Szeged, Hungary; and 3 Department of Veterinary and Comparative Anatomy, Pharmacology and Physiology, Washington State University, Pullman, Washington 99164-6520
The effects of intracerebroventricular injections of the long-lasting somatostatin analog octreotide (Oct) were studied on sleep and behavior in rats. Pyrogen-free physiological saline and Oct (0.001, 0.01, 0.1 µg) or vehicle were administered at light onset, and the electroencephalogram (EEG), motor activity, and cortical brain temperature were recorded during the 12-h light period. Plasma growth hormone (GH) concentrations were measured in samples taken at 30-min intervals after Oct. Oct (0.01 and 0.1 µg) suppressed non-rapid eye movement sleep (NREMS) for 1-2 h. NREMS intensity (delta EEG activity during NREMS) dose dependently increased in hour 3 postinjection and thereafter (0.1 µg). Plasma GH concentrations were suppressed after Oct (0.01 and 0.1 µg), but pulses of GH secretions occurred 90-120 min postinjection in each rat. Oct (0.1 µg) enhanced behavioral activity, including prompt drinking followed by grooming, scratching, and feeding. Intracerebroventricular injection of the angiotensin-converting enzyme inhibitor captopril (30 µg, 10 min before Oct), blocked these behavioral responses but not the Oct-induced sleep alterations. The changes in sleep after intracerebroventricular Oct suggest an intracerebral action site and might result from Oct-induced variations in the sleep-promoting activity of GH-releasing hormone.
growth hormone; angiotensin; drinking; growth hormone-releasing hormone; rat
This article has been cited by other articles:
|
|
 |
|
  E. Szentirmai, T. Yasuda, P. Taishi, M. Wang, L. Churchill, S. Bohnet, P. Magrath, B. Kacsoh, L. Jimenez, and J. M. Krueger Growth hormone-releasing hormone: cerebral cortical sleep-related EEG actions and expression Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2007; 293(2): R922 - R930. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. C. Weikel, A. Wichniak, M. Ising, H. Brunner, E. Friess, K. Held, S. Mathias, D. A. Schmid, M. Uhr, and A. Steiger Ghrelin promotes slow-wave sleep in humans Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E407 - E415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Obal Jr., J. Alt, P. Taishi, J. Gardi, and J. M. Krueger Sleep in mice with nonfunctional growth hormone-releasing hormone receptors Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R131 - R139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Obal Jr, J. Fang, P. Taishi, B. Kacsoh, J. Gardi, and J. M. Krueger Deficiency of Growth Hormone-Releasing Hormone Signaling Is Associated with Sleep Alterations in the Dwarf Rat J. Neurosci., April 15, 2001; 21(8): 2912 - 2918. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Hajdu, F. Obal Jr., J. Gardi, F. Laczi, and J. M. Krueger Octreotide-induced drinking, vasopressin, and pressure responses: role of central angiotensin and ACh Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2000; 279(1): R271 - R277. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Hajdu, F. Obal Jr., J. Fang, J. M. Krueger, and C. D. Rollo Sleep of transgenic mice producing excess rat growth hormone Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2002; 282(1): R70 - R76. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
